![](https://investorshub.advfn.com/uicon/430424.png?cb=1554906782)
Thursday, September 18, 2014 6:33:46 PM
Tumor infiltration with t and b cells in the UCLA phase II Direct study and MD Anderson phase I Direct study demonstrate the injected cells are making it to the lymph nodes, and the t and b cells are targeting tumors, and apparently they are not just targeting the bacterium antigens, but they are targeting the actual tumor antigens as well.
As I stated before, Dendritic cells work in phases. The first phase, which remains ongoing, occurs right after the dendritic cell is injected into the tumor. This is when the DC secretes massive amounts of cytokine that directly and indirectly kill the tumor and create inflammation. The dendritic cell can then uptake tumor debris/antigens/biomarkers/proteins and express them to T and B cells back at the lymph nodes and spleen. The second wave of tumor killing occurs when these T and B cells infiltrate the tumor. This cycle can repeat itself. My personal opinion is that patience will be rewarded. The second phase takes longer than the first, and NWBO appears to believe the second wave initiates somewhere between 8 (4th injection) and 32 weeks (6th injection). Immune memory, if it is to occur, is the last phase.
My position is that there are early glimpses of systemic response. IMHO. I also posted other messages than just giving a layman's description of cancer mutation and the need to inject multiple tumors. Multiple injections, IMHO, are also important to soften the large tumor battlefields and it gives DC's the opportunity to gather more tumor debris at an earlier stage. I think you misconstrued my position somewhat. I give Foxhound the floor on this matter (cancer mutation rate) (I think he is correct), but I have read a great deal in the past regarding how cancer escapes various therapies. Mutation is one way, immunosuppression is yet another. There are approximately 11 identified Hallmarks of Cancer. I stand by my comment that, IMHO, every time you inject a new tumor, you are essentially creating a new vaccine due to the rapid rate at which mutation occurs.
I highly suggest anyone interested in cancer biology, suppression and escape review the "Hallmarks of Cancer" and the "Hallmarks of Cancer, the Next Generation." It is a peer reviewed article that has been cited over 15,000 times in other peer reviewed articles. The latter discusses mutation rate and chromosome abnormalities. You also get a very good feel for why large tumors are exceptionally good at creating a tumor suppressing environment.
Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM